Skip to main content

Alexion.US

This site is intended for US audiences. If you are in another region, please visit our global site to learn more or be directed to your local country page.

Gianluca Pirozzi

SVP, Head of Development, Regulatory and Safety

Gianluca Pirozzi

About Gianluca

Gianluca joined Alexion in October 2019 and currently leads the company’s integrated Development, Regulatory and Safety organization. Previously, he served in various roles at Sanofi Genzyme, including Head of Development for Rare Diseases and Gene Therapy. He has served on the Board of Directors of Imbria Pharmaceuticals for two years, and is currently Board Member of Timber Pharmaceuticals, as well as scientific advisor for the Smith-Magenis Syndrome Research Foundation.

Gianluca holds an MD degree from University Campus Bio-Medico and a PhD in Immunology from Sapienza University, both in Rome, Italy, and completed a Post Doctoral Research Fellowship in Immunology at the Pasteur Institute in Paris, France.